LONDON (Alliance News) - Syncona Ltd on Tuesday said it was encouraged by portfolio firm Blue Earth Diagnostics prostate cancer imaging tests results.The healthcare company said that a on a Read More
LONDON (Alliance News) - Syncona Ltd on Thursday said that a merger between its two units Gyroscope Therapeutics and Orbit Biomedical created the first fully integrated retinal gene therapy will a Read More
LONDON (Alliance News) - The Wellcome Trust Ltd on Wednesday said it will sell a small percentage of its shareholding in Syncona Ltd by way of a placing.The placing is expected to include a Read More
LONDON (Alliance News) - Life sciences investor Syncona Ltd on Tuesday said it will significantly reduce its fund investments over the next three to six months as it works to simplify the of its a Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday:----------FTSE 100 - up 4.2%. Shares in the company were from on - Read More
LONDON (Alliance News) - Syncona Ltd on Monday said investee company Nightsar Therapeutics PLC has agreed to be acquired by neuroscience healthcare firm Biogen Inc for USD877 million, giving a 72% Read More
LONDON (Alliance News) - FTSE 250-listed healthcare-focused investor Syncona Ltd on Monday reported on progress made by portfolio company, Nasdaq-listed Autolus Therapeutics Inc, on its has dosed Read More
LONDON (Alliance News) - Syncona Ltd on Wednesday reported a more than doubled profit for the first half of its financial year, boosted by fair value gains amid a strong total return for the the a Read More
LONDON (Alliance News) - Healthcare-focused investment firm Syncona Ltd said Friday it has invested a further USD18 million in NASDAQ-listed Nightstar Therapeutics PLC after its announced a share Read More
LONDON (Alliance News) - FTSE 250-listed healthcare investor Syncona Ltd said on Monday its portfolio company Nightstar Therapeutics PLC reported positive results from the dose escalation study in Read More
LONDON (Alliance News) - Healthcare investor Syncona Ltd said Thursday its net assets increased significantly in its financial first quarter, due to the strong performance and increasing size of a Read More
LONDON (Alliance News) - FTSE 250-listed healthcare investment company Syncona Ltd said on Tuesday it has invested GBP85 million in Adeno-associated virus gene therapy company virus is a small and Read More
LONDON (Alliance News) - Syncona Ltd on Thursday said strong results from its science portfolio and new investments resulted in an increased return for the 2018 financial year.The FTSE life Read More
(Correcting Syncona and Woodford's shareholding value in Autolus Therapeutics following the ADS offering)LONDON (Alliance News) - Healthcare investor Syncona Ltd said Friday that its an Read More
LONDON (Alliance News) - Healthcare investor Syncona Ltd on Tuesday noted the proposed listing of American depositary shares on the Nasdaq Global Market by investee Autolus Therapeutics said the Read More
LONDON (Alliance News) - Life science focused investment trust Syncona Ltd said Wednesday its portfolio company Blue Earth Diagnostics has signed an exclusive licence for a radio-hybride prostate Read More
LONDON (Alliance News) - Healthcare-focused investment company Syncona Ltd said on Wednesday that itsportfolio company Nightstar Therapeutics PLC reported a widened loss in as Read More
LONDON (Alliance News) - Syncona Ltd said on Tuesday it has revised its investment management agreement with BACIT UK Ltd in order to reduce costs for has Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Smurfit up it Read More
LONDON (Alliance News) - FTSE 250-listed healthcare investment company Syncona Ltd said on Tuesday its portfolio company Autolus Ltd, has filed a confidential submission of a Read More